vs

Side-by-side financial comparison of NEOGENOMICS INC (NEO) and Ribbon Communications Inc. (RBBN). Click either name above to swap in a different company.

NEOGENOMICS INC is the larger business by last-quarter revenue ($186.7M vs $162.6M, roughly 1.1× Ribbon Communications Inc.). Ribbon Communications Inc. runs the higher net margin — 54.8% vs -57.9%, a 112.6% gap on every dollar of revenue. On growth, NEOGENOMICS INC posted the faster year-over-year revenue change (11.1% vs -10.3%). Over the past eight quarters, NEOGENOMICS INC's revenue compounded faster (6.5% CAGR vs -8.1%).

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

Ribbon Communications Inc. is a public company that makes software, IP and optical networking solutions for service providers, enterprises and critical infrastructure sectors. The company was formed in 2017, following the merger of Genband and Sonus Networks and is headquartered in Plano, Texas.

NEO vs RBBN — Head-to-Head

Bigger by revenue
NEO
NEO
1.1× larger
NEO
$186.7M
$162.6M
RBBN
Growing faster (revenue YoY)
NEO
NEO
+21.4% gap
NEO
11.1%
-10.3%
RBBN
Higher net margin
RBBN
RBBN
112.6% more per $
RBBN
54.8%
-57.9%
NEO
Faster 2-yr revenue CAGR
NEO
NEO
Annualised
NEO
6.5%
-8.1%
RBBN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
NEO
NEO
RBBN
RBBN
Revenue
$186.7M
$162.6M
Net Profit
$-108.0M
$89.1M
Gross Margin
43.3%
42.9%
Operating Margin
46.9%
37.6%
Net Margin
-57.9%
54.8%
Revenue YoY
11.1%
-10.3%
Net Profit YoY
42.0%
EPS (diluted)
$-0.13
$0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NEO
NEO
RBBN
RBBN
Q1 26
$186.7M
$162.6M
Q4 25
$190.2M
$227.3M
Q3 25
$187.8M
$215.4M
Q2 25
$181.3M
$220.6M
Q1 25
$168.0M
$181.3M
Q4 24
$172.0M
$251.4M
Q3 24
$167.8M
$210.2M
Q2 24
$164.5M
$192.6M
Net Profit
NEO
NEO
RBBN
RBBN
Q1 26
$-108.0M
$89.1M
Q4 25
Q3 25
$-27.1M
$-12.1M
Q2 25
$-45.1M
$-11.1M
Q1 25
$-25.9M
$-26.2M
Q4 24
Q3 24
$-17.7M
$-13.4M
Q2 24
$-18.6M
$-16.8M
Gross Margin
NEO
NEO
RBBN
RBBN
Q1 26
43.3%
42.9%
Q4 25
43.8%
53.3%
Q3 25
42.8%
50.1%
Q2 25
42.6%
49.6%
Q1 25
43.6%
45.4%
Q4 24
44.9%
55.7%
Q3 24
44.6%
52.1%
Q2 24
44.1%
50.8%
Operating Margin
NEO
NEO
RBBN
RBBN
Q1 26
46.9%
37.6%
Q4 25
-7.1%
4.1%
Q3 25
-14.4%
1.3%
Q2 25
-26.3%
1.9%
Q1 25
-16.6%
-10.8%
Q4 24
-10.7%
13.2%
Q3 24
-12.6%
-0.4%
Q2 24
-13.3%
-1.0%
Net Margin
NEO
NEO
RBBN
RBBN
Q1 26
-57.9%
54.8%
Q4 25
Q3 25
-14.4%
-5.6%
Q2 25
-24.9%
-5.0%
Q1 25
-15.4%
-14.5%
Q4 24
Q3 24
-10.5%
-6.4%
Q2 24
-11.3%
-8.7%
EPS (diluted)
NEO
NEO
RBBN
RBBN
Q1 26
$-0.13
$0.50
Q4 25
$0.50
Q3 25
$-0.07
Q2 25
$-0.06
Q1 25
$-0.15
Q4 24
$0.05
Q3 24
$-0.08
Q2 24
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NEO
NEO
RBBN
RBBN
Cash + ST InvestmentsLiquidity on hand
$146.1M
$67.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$828.8M
$419.1M
Total Assets
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NEO
NEO
RBBN
RBBN
Q1 26
$146.1M
$67.6M
Q4 25
$159.6M
$96.4M
Q3 25
$164.1M
$74.8M
Q2 25
$154.7M
$60.5M
Q1 25
$346.2M
$71.2M
Q4 24
$367.0M
$87.8M
Q3 24
$362.0M
$37.2M
Q2 24
$355.1M
$64.6M
Total Debt
NEO
NEO
RBBN
RBBN
Q1 26
Q4 25
$341.9M
$342.1M
Q3 25
$344.3M
Q2 25
$346.5M
Q1 25
$347.4M
Q4 24
$541.1M
$348.3M
Q3 24
$349.1M
Q2 24
$350.0M
Stockholders' Equity
NEO
NEO
RBBN
RBBN
Q1 26
$828.8M
$419.1M
Q4 25
$836.6M
$449.0M
Q3 25
$838.3M
$360.1M
Q2 25
$854.0M
$370.4M
Q1 25
$888.3M
$381.8M
Q4 24
$902.3M
$404.6M
Q3 24
$908.2M
$395.5M
Q2 24
$915.9M
$405.0M
Total Assets
NEO
NEO
RBBN
RBBN
Q1 26
$1.3B
Q4 25
$1.4B
$1.2B
Q3 25
$1.4B
$1.1B
Q2 25
$1.4B
$1.1B
Q1 25
$1.6B
$1.1B
Q4 24
$1.6B
$1.2B
Q3 24
$1.6B
$1.1B
Q2 24
$1.6B
$1.1B
Debt / Equity
NEO
NEO
RBBN
RBBN
Q1 26
Q4 25
0.41×
0.76×
Q3 25
0.96×
Q2 25
0.94×
Q1 25
0.91×
Q4 24
0.60×
0.86×
Q3 24
0.88×
Q2 24
0.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NEO
NEO
RBBN
RBBN
Operating Cash FlowLast quarter
$-8.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NEO
NEO
RBBN
RBBN
Q1 26
$-8.1M
Q4 25
$1.3M
$29.2M
Q3 25
$8.9M
$26.5M
Q2 25
$20.3M
$-795.0K
Q1 25
$-25.3M
$-3.5M
Q4 24
$9.8M
$61.8M
Q3 24
$9.2M
$-14.8M
Q2 24
$13.9M
$-9.8M
Free Cash Flow
NEO
NEO
RBBN
RBBN
Q1 26
Q4 25
$-6.5M
$27.3M
Q3 25
$570.0K
$21.0M
Q2 25
$14.0M
$-6.5M
Q1 25
$-29.8M
$-15.7M
Q4 24
$-1.8M
$53.8M
Q3 24
$-1.6M
$-23.7M
Q2 24
$814.0K
$-12.9M
FCF Margin
NEO
NEO
RBBN
RBBN
Q1 26
Q4 25
-3.4%
12.0%
Q3 25
0.3%
9.7%
Q2 25
7.7%
-2.9%
Q1 25
-17.8%
-8.7%
Q4 24
-1.0%
21.4%
Q3 24
-0.9%
-11.3%
Q2 24
0.5%
-6.7%
Capex Intensity
NEO
NEO
RBBN
RBBN
Q1 26
Q4 25
4.1%
0.9%
Q3 25
4.4%
2.6%
Q2 25
3.5%
2.6%
Q1 25
2.7%
6.7%
Q4 24
6.7%
3.2%
Q3 24
6.4%
4.2%
Q2 24
8.0%
1.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NEO
NEO

Segment breakdown not available.

RBBN
RBBN

Service$94.5M58%
Product$68.1M42%

Related Comparisons